![Ronald Stafford Watts](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ronald Stafford Watts
Directeur/Bestuurslid bij Wenkart Foundation
Actieve functies van Ronald Stafford Watts
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Wenkart Foundation | Directeur/Bestuurslid | - | - |
Biosceptre International Ltd.
![]() Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | Directeur/Bestuurslid | - | - |
Loopbaan van Ronald Stafford Watts
Eerdere bekende functies van Ronald Stafford Watts
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ENERGY ACTION LIMITED | Directeur/Bestuurslid | 12-11-2015 | 30-06-2017 |
Voorzitter | 14-10-2011 | 12-11-2015 | |
Biosceptre (Aust) Pty Ltd.
![]() Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Directeur/Bestuurslid | - | - |
Opleiding van Ronald Stafford Watts
The University of New South Wales | Undergraduate Degree |
University of Cambridge | Doctorate Degree |
Statistieken
Internationaal
Australië | 5 |
Verenigd Koninkrijk | 3 |
Operationeel
Director/Board Member | 4 |
Chairman | 1 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ENERGY ACTION LIMITED | Commercial Services |
Bedrijven in privébezit | 3 |
---|---|
Biosceptre (Aust) Pty Ltd.
![]() Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Health Technology |
Wenkart Foundation | |
Biosceptre International Ltd.
![]() Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | Health Technology |